Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
6Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
RxSight, Inc. (RXST) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
15Total relationships
3Distinct source URLs
8High confidence
0.794Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
RxSight, Inc. Suppliers
Ticker
Name
Confidence
Evidence
SINGLE-AND-SOLE-SOURCE-SUPPLIERS
SINGLE-AND-SOLE-SOURCE-SUPPLIERS
92%
We rely on third parties, including single and sole source suppliers, to manufacture certain components and subcomponents of our products and to provide raw materials, primarily chemicals for our LAL.
CERTIFIED-SPECIALTY-CONTRACT-MANUFACTURERS
CERTIFIED-SPECIALTY-CONTRACT-MANUFACTURERS
90%
We outsource the cables and circuit boards used in the LDD to certified specialty contract manufacturers.
THIRD-PARTY-STERILIZATION-VENDOR
THIRD-PARTY-STERILIZATION-VENDOR
85%
We also employ a third-party sterilization vendor.
f our RxSight system is beneficial in a broad range of patients, adoption of our product will be limited and may not occur as rapidly as we anticipate or at all, which would have a material adverse e…
Reciprocal relationship from JNJ graph: Reciprocal relationship from RXST graph: f our RxSight system is beneficial in a broad range of patients, adoption of our product will be limited and may not o…
RxSight, Inc. Customers
Ticker
Name
Confidence
Evidence
AMBULATORY-SURGERY-CENTERS
AMBULATORY-SURGERY-CENTERS
90%
The Company maintains an allowance for credit losses resulting from the inability of its customers, including ambulatory surgery centers, to make required payments.
f our RxSight system is beneficial in a broad range of patients, adoption of our product will be limited and may not occur as rapidly as we anticipate or at all, which would have a material adverse e…
Reciprocal relationship from JNJ graph: Reciprocal relationship from RXST graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from RXST graph: f our RxSight system is beneficial in…
BOFA-SECURITIES-INC
BOFA-SECURITIES-INC
62%
mprehensive loss. Unrealized losses on available-for-sale debt securities as of December 31, 2024 and December 31, 2023 were not significant and were primarily due to changes in interest rates, inclu…
CALHOUN-VISION-INC
CALHOUN-VISION-INC
62%
performance obligation is satisfied, and revenue from sales is recognized for LALs upon customer notification that the LALs have been implanted in a patient or when title transfers to the distributor…
EXHIBIT-INDEX-EXHIBIT-INCORPORATED
EXHIBIT-INDEX-EXHIBIT-INCORPORATED
62%
required on terms that are acceptable to us, or at all, and our third-party manufacturers and suppliers may not be able to allocate sufficient capacity in order to meet our increased requirements, an…
RxSight, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
RXST-DEBT-12328
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-09-30.
RXST-DEBT-12327
Warrants outstanding: 100261
90%
xbrl warrant detail from xbrl 2022-12-31.
RXST-DEBT
Debt stack $10.8M
90%
Market cache reports total debt of $10.8M.
RxSight, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for RxSight, Inc..
RxSight, Inc. Ownership
Holder
Name
Confidence
Evidence
RXST-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 164 tracked holders.
